← All Spyglass Pharma, INC filings

Spyglass Pharma, INC Schedule 13D activist filings

Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.

NASDAQ
SGP
Spyglass Pharma, INC
SCHEDULE: NEA Funds Disclose 22.2% Stake in SpyGlass Pharma Post-IPO
New Enterprise Associates funds and their managers have filed a Schedule 13D, revealing a significant 22.2% beneficial ownership in SpyGlass Pharma, Inc. following its recent IPO.
NASDAQ
SGP
Spyglass Pharma, INC
SCHEDULE: Vensana Capital Reports 9.9% Stake in SpyGlass Pharma Post-IPO
Vensana Capital I, L.P. and its affiliates have reported a 9.9% beneficial ownership stake in SpyGlass Pharma, Inc. following the company's initial public offering.